China's Sinopharm says coronavirus vaccine could be ready by year-end


FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/

BEIJING: A coronavirus vaccine candidate developed by China National Pharmaceutical Group (Sinopharm) could be ready for public use by the end of this year, state media reported on Wednesday, ahead of a previous expectation it may become available in 2021.

Sinopharm Chairman Liu Jingzhen told state broadcaster CCTV the company expects to finish late-stage human testing within about three months.

Unlock 30% Savings on Ad-Free Access Now!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

SkyWorld buys land in Penang for RM49mil to develop affordable homes
PNSB, SD Guthrie, IJM and Yayasan Selangor to initiate food security and edu-tech hub
Malaysia scores RM1.16bil in potential sales at Paris Airshow
Ho Wah Genting redesignates ED Lim Wee Kiat as CEO
Ringgit eases against US dollar on US tariff adjustments
Aeon Credit net profit falls 27% to RM77.5mil in 1Q
Lebtech secures RM1.25mil meteorological contract
Bursa Malaysia dips as Trump's 25% tariff on Malaysia rattles investors
UOB Malaysia, Maybank IB support PBAPP’s RM5bil sukuk for water infrastructure
AirAsia eyes increased connectivity to Penang in regional expansion push

Others Also Read